Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Mette L Schousboe"'
Autor:
Mette L Schousboe, Samir Ranjitkar, Rupika S Rajakaruna, Priyanie H Amerasinghe, Francisco Morales, Richard Pearce, Rosalyn Ord, Toby Leslie, Mark Rowland, Nahla B Gadalla, Flemming Konradsen, Ib C Bygbjerg, Cally Roper, Michael Alifrangis
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 9, Iss 11, p e0004196 (2015)
BACKGROUND:Chloroquine combined with primaquine has been the recommended antimalarial treatment of Plasmodium vivax malaria infections for six decades but the efficacy of this treatment regimen is threatened by chloroquine resistance (CQR). Single nu
Externí odkaz:
https://doaj.org/article/143310ab5cc74219b442fdc400526442
Autor:
Michael Alifrangis, Sidsel Nag, Mette L. Schousboe, Deus S. Ishengoma, John Lusingu, Hirva Pota, Reginald A. Kavishe, Richard Pearce, Rosalynn Ord, Caroline Lynch, Seyoum Dejene, Jonathan Cox, John Rwakimari, Daniel T.R. Minja, Martha M. Lemnge, Cally Roper
Publikováno v:
Emerging Infectious Diseases, Vol 20, Iss 8, Pp 1280-1286 (2014)
Super-resistant Plasmodium falciparum threatens the effectiveness of sulfadoxine–pyrimethamine in intermittent preventive treatment for malaria during pregnancy. It is characterized by the A581G Pfdhps mutation on a background of the double-mutant
Externí odkaz:
https://doaj.org/article/517181b53a6f4e038e0639a57e65db56
Autor:
Richard Pearce, Rosalynn Ord, Mette L Schousboe, Michael Alifrangis, John B. Rwakimari, Caroline A. Lynch, Daniel T. R. Minja, Cally Roper, Reginald A. Kavishe, Jonathan Cox, Hirva Pota, Sidsel Nag, Martha M. Lemnge, John Lusingu, Seyoum Dejene, Deus S. Ishengoma
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 20, Iss 8, Pp 1280-1286 (2014)
Emerging Infectious Diseases, Vol 20, Iss 8, Pp 1280-1286 (2014)
Comprehensive surveillance is needed to support sulfadoxine–pyrimethamine intermittent preventive treatment in pregnant women.
Super-resistant Plasmodium falciparum threatens the effectiveness of sulfadoxine–pyrimethamine in intermittent pre
Super-resistant Plasmodium falciparum threatens the effectiveness of sulfadoxine–pyrimethamine in intermittent pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e4c3383c16ec827c6de8cf9596282b5
https://doi.org/10.3201/eid2008.131897
https://doi.org/10.3201/eid2008.131897
Autor:
Mette L Schousboe, Priyanie H. Amerasinghe, Rupika S. Rajakaruna, Michael Alifrangis, Richard Pearce, Rosalynn Ord, Ib C. Bygbjerg, Flemming Konradsen, Cally Roper
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 85:994-1001
The geographical distribution of genetic variation in Plasmodium vivax samples ( N = 386) from nine dis- tricts across Sri Lanka is described using three markers; the P. vivax merozoite surface protein -3α ( Pvmsp -3α) gene, and the two microsatell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbf42eb8a6a19209b0c0bfad9bc13f07
https://doi.org/10.4269/ajtmh.2011.11-0338
https://doi.org/10.4269/ajtmh.2011.11-0338
Autor:
Mette L Schousboe, Michael Alifrangis, Flemming Konradsen, Daniel L. Hartl, Richard J. Pollack, Marcelo U. Ferreira, Dyann F. Wirth, Sharmini Gunawardena, Myatt Phone-Kyaw, Nadira D. Karunaweera, Rabindra R Abeyasinghe, Gawrie N. L. Galappaththy, Priyanie H. Amerasinghe, Rupika S. Rajakaruna
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 82:235-242
Genetic diversity and population structure of Plasmodium vivax parasites can predict the origin and spread of novel variants within a population enabling population specific malaria control measures. We analyzed the genetic diversity and population s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::760428787a67ea3c72a36f89cc976874
https://doi.org/10.4269/ajtmh.2010.09-0588
https://doi.org/10.4269/ajtmh.2010.09-0588
Autor:
Rupika S. Rajakaruna, Mette L Schousboe, Michael Alifrangis, Cally Roper, Nahla B Gadalla, Francisco Morales, Samir Ranjitkar, Mark Rowland, Flemming Konradsen, Ib C. Bygbjerg, Priyanie H. Amerasinghe, Toby Leslie, Richard Pearce, Rosalynn Ord
Publikováno v:
Malaria Journal
Background Even though Plasmodium vivax has the widest worldwide distribution of the human malaria species and imposes a serious impact on global public health, the investigation of genetic diversity in this species has been limited in comparison to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48a9c108715983b6e2741858a942f759
https://researchonline.lshtm.ac.uk/id/eprint/2006442/1/392
https://researchonline.lshtm.ac.uk/id/eprint/2006442/1/392
Autor:
Madhav Adhikari, Mette L Schousboe, Thomas T. Thomsen, Christian M. O. Kapel, Samir Ranjitkar, Ib C. Bygbjerg, Michael Alifrangis
Publikováno v:
Malaria Journal, Vol 10, Iss 1, p 75 (2011)
Malaria Journal
Malaria Journal
Background Sulphadoxine-pyrimethamine (SP) and chloroquine (CQ) have been used in treatment of falciparum and vivax malaria in Nepal. Recently, resistance to both drugs have necessitated a change towards artemisinin combination therapy (ACT) against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98a4211d47ebf8524b17084971284ef2
http://www.malariajournal.com/content/10/1/75
http://www.malariajournal.com/content/10/1/75
Autor:
Francisco Morales, Samir Ranjitkar, Toby Leslie, Mark Rowland, Rosalyn Ord, Flemming Konradsen, Richard Pearce, Priyanie H. Amerasinghe, Cally Roper, Ib C. Bygbjerg, Mette L Schousboe, Michael Alifrangis, Nahla B Gadalla, Rupika S. Rajakaruna
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 9, Iss 11, p e0004196 (2015)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Background Chloroquine combined with primaquine has been the recommended antimalarial treatment of Plasmodium vivax malaria infections for six decades but the efficacy of this treatment regimen is threatened by chloroquine resistance (CQR). Single nu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3cd7c78287dd9e12833bbeb50139bcf
https://doi.org/10.1371/journal.pntd.0004196
https://doi.org/10.1371/journal.pntd.0004196
Autor:
Mette L Schousboe, Maria Tseroni, Michael Alifrangis, Jenny Kremastinou, Eleni Patsoula, Helle H Hansson, Christos Hadjichristodoulou, Ib C. Bygbjerg, Gregory Spanakos, Nicholas Vakalis, Nicholas Tegos
Publikováno v:
Malaria Journal
Background Plasmodium vivax malaria was common in Greece until the 1950s with epidemics involving thousands of cases every year. Greece was declared free of malaria by the World Health Organization in 1974. From 1974 to 2010, an average of 39 cases p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86853e69d553b73d6d8086be60713e75
http://europepmc.org/articles/PMC3877964
http://europepmc.org/articles/PMC3877964
Autor:
Mette L Schousboe, Rupika S. Rajakaruna, Priyanie H. Amerasinghe, Hapuarachchige Chanditha Hapuarachchi, Michael Alifrangis, Gawrie N. L. Galappaththy, Ib C. Bygbjerg, Ali Salanti, Flemming Konradsen
Publikováno v:
Malaria Journal
Malaria Journal, Vol 6, Iss 1, p 28 (2007)
Malaria Journal, Vol 6, Iss 1, p 28 (2007)
Background Single nucleotide polymorphisms (SNPs) in the Plasmodium vivax dihydrofolate reductase (Pfdhfr) and dihydropteroate synthetase (Pvdhps) genes cause parasite resistance to the antifolate drug combination, sulphadoxine/pyrimethamine (SP). Mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2ef35bdc7f20cbe3578d4b9991a4ba5
http://europepmc.org/articles/PMC1831779
http://europepmc.org/articles/PMC1831779